HCM
HUTCHMED (China) Limited
Drug Manufacturers - Specialty & Generic
Market Cap$2.29B
5Y Perf.-39.0%
Compare Stocks
5 / 10Try these comparisons:
Stock Comparison
HCM vs CAN vs MARA vs ZLAB vs RIOT
Revenue, margins, valuation, and 5-year total return — side by side.
CAN
Canaan Inc.
Computer Hardware
Market Cap$331M
5Y Perf.-78.2%
MARA
Marathon Digital Holdings, Inc.
Financial - Capital Markets
Market Cap$4.83B
5Y Perf.+1714.3%
ZLAB
Zai Lab Limited
Biotechnology
Market Cap$2.19B
5Y Perf.-73.4%
RIOT
Riot Platforms, Inc.
Financial - Capital Markets
Market Cap$9.14B
5Y Perf.+1026.6%
HCM vs CAN vs MARA vs ZLAB vs RIOT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | HCM | CAN | MARA | ZLAB | RIOT |
|---|---|---|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Computer Hardware | Financial - Capital Markets | Biotechnology | Financial - Capital Markets |
| Market Cap | $2.29B | $331M | $4.83B | $2.19B | $9.14B |
| Revenue (TTM) | $602M | $530M | $907M | $460M | $647M |
| Net Income (TTM) | $467M | $-210M | $-1.31B | $-176M | $-867M |
| Gross Margin | 8.9% | 7.8% | -47.7% | 58.5% | -15.6% |
| Operating Margin | -3.3% | -21.0% | -90.6% | -49.9% | -61.8% |
| Forward P/E | 41.7x | — | — | — | — |
| Total Debt | $90M | $55M | $3.65B | $224M | $280M |
| Cash & Equiv. | $154M | $81M | $547M | $680M | $234M |
HCM vs CAN vs MARA vs ZLAB vs RIOT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
HCM
CAN
MARA
ZLAB
RIOT
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| HUTCHMED (China) Li… (HCM) | 100 | 61.0 | -39.0% |
| Canaan Inc. (CAN) | 100 | 21.8 | -78.2% |
| Marathon Digital Ho… (MARA) | 100 | 1814.3 | +1714.3% |
| Zai Lab Limited (ZLAB) | 100 | 26.6 | -73.4% |
| Riot Platforms, Inc. (RIOT) | 100 | 1126.6 | +1026.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HCM vs CAN vs MARA vs ZLAB vs RIOT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: HCM leads in 3 of 7 categories (5-stock set), making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Canaan Inc. is the stronger pick specifically for growth and revenue expansion. MARA and RIOT also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
HCM
HUTCHMED (China) Limited
The Defensive Pick
HCM carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.
- Lower volatility, beta 0.66, Low D/E 11.6%, current ratio 2.83x
- Beta 0.66, current ratio 2.83x
- 77.5% margin vs MARA's -144.6%
- Beta 0.66 vs CAN's 4.41, lower leverage
Best for: sleep-well-at-night and defensive
CAN
Canaan Inc.
The Growth Play
CAN is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 96.7%, EPS growth 51.1%, 3Y rev CAGR -6.7%
- 96.7% revenue growth vs HCM's -24.8%
Best for: growth exposure
MARA
Marathon Digital Holdings, Inc.
The Banking Pick
MARA ranks third and is worth considering specifically for value.
- Better valuation composite
Best for: value
ZLAB
Zai Lab Limited
The Healthcare Pick
Among these 5 stocks, ZLAB doesn't own a clear edge in any measured category.
Best for: healthcare exposure
RIOT
Riot Platforms, Inc.
The Banking Pick
RIOT is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 3.87
- 7.9% 10Y total return vs HCM's 1.0%
- +207.5% vs ZLAB's -30.3%
Best for: income & stability and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | CAN | 96.7% revenue growth vs HCM's -24.8% |
| Value | MARA | Better valuation composite |
| Quality / Margins | HCM | 77.5% margin vs MARA's -144.6% |
| Stability / Safety | HCM | Beta 0.66 vs CAN's 4.41, lower leverage |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | RIOT | +207.5% vs ZLAB's -30.3% |
| Efficiency (ROA) | HCM | 30.6% ROA vs CAN's -34.9%, ROIC -5.2% vs -24.9% |
HCM vs CAN vs MARA vs ZLAB vs RIOT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2023
FY 2024
FY 2025
FY 2025
FY 2025
HCM vs CAN vs MARA vs ZLAB vs RIOT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLHCMLAGGINGZLAB
Who Leads Where
HCM leads in 2 of 6 categories
RIOT leads 2 • CAN leads 1 • MARA leads 0 • ZLAB leads 0 • 1 tied
Explore the data ↓ZLABZai Lab Limited
0leads
MARAMarathon Digital Hold…
0leads
CANCanaan Inc.
1leads
RIOTRiot Platforms, Inc.
2leads
HCMHUTCHMED (China) Limi…
2leads
6 Total Categories
CATEGORYLEADERvs RIOTvs CANMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
HCM4/6
Valuation MetricsMultiples, price ratios, and targets
CAN2/3
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
HCM4/9
Total Returns1Y, 3Y, 5Y total returns with dividends
RIOT6/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
RIOT1/1
Income & Cash Flow (Last 12 Months)
HCM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MARA is the larger business by revenue, generating $907M annually — 2.0x ZLAB's $460M. HCM is the more profitable business, keeping 77.5% of every revenue dollar as net income compared to MARA's -144.6%. On growth, CAN holds the edge at +121.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | HCMHUTCHMED (China) … | CANCanaan Inc. | MARAMarathon Digital … | ZLABZai Lab Limited | RIOTRiot Platforms, I… |
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $602M | $530M | $907M | $460M | $647M |
| EBITDAEarnings before interest/tax | -$7M | -$66M | $627M | -$214M | -$450M |
| Net IncomeAfter-tax profit | $467M | -$210M | -$1.3B | -$176M | -$867M |
| Free Cash FlowCash after capex | -$50M | $0 | -$312M | -$159M | -$1.0B |
| Gross MarginGross profit ÷ Revenue | +8.9% | +7.8% | -47.7% | +58.5% | -15.6% |
| Operating MarginEBIT ÷ Revenue | -3.3% | -21.0% | -90.6% | -49.9% | -61.8% |
| Net MarginNet income ÷ Revenue | +77.5% | -39.7% | -144.6% | -38.1% | -102.4% |
| FCF MarginFCF ÷ Revenue | -8.2% | — | -34.4% | -34.5% | -119.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -9.2% | +121.1% | — | +17.0% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +16.6% | +59.4% | -4.8% | +42.5% | -60.0% |
HCM leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
CAN leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | HCMHUTCHMED (China) … | CANCanaan Inc. | MARAMarathon Digital … | ZLABZai Lab Limited | RIOTRiot Platforms, I… |
|---|---|---|---|---|---|
| Market CapShares × price | $2.3B | $331M | $4.8B | $2.2B | $9.1B |
| Enterprise ValueMkt cap + debt − cash | $2.2B | $305M | $7.9B | $1.7B | $9.2B |
| Trailing P/EPrice ÷ TTM EPS | 60.50x | -1.14x | -3.44x | -12.35x | -12.36x |
| Forward P/EPrice ÷ next-FY EPS est. | 41.66x | — | — | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | — | — | — |
| Price / SalesMarket cap ÷ Revenue | 3.63x | 0.62x | 5.32x | 4.75x | 14.12x |
| Price / BookPrice ÷ Book value/share | 3.01x | 0.55x | 1.30x | 3.03x | 2.87x |
| Price / FCFMarket cap ÷ FCF | — | — | — | — | — |
CAN leads this category, winning 2 of 3 comparable metrics.
Profitability & Efficiency
HCM leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
HCM delivers a 46.4% return on equity — every $100 of shareholder capital generates $46 in annual profit, vs $-48 for CAN. RIOT carries lower financial leverage with a 0.10x debt-to-equity ratio, signaling a more conservative balance sheet compared to MARA's 1.05x. On the Piotroski fundamental quality scale (0–9), CAN scores 6/9 vs RIOT's 3/9, reflecting solid financial health.
| Metric | HCMHUTCHMED (China) … | CANCanaan Inc. | MARAMarathon Digital … | ZLABZai Lab Limited | RIOTRiot Platforms, I… |
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +46.4% | -48.1% | -30.5% | -22.8% | -28.8% |
| ROA (TTM)Return on assets | +30.6% | -34.9% | -17.1% | -15.0% | -21.5% |
| ROICReturn on invested capital | -5.2% | -24.9% | -9.0% | -42.8% | -8.7% |
| ROCEReturn on capital employed | -4.9% | -29.7% | -12.1% | -27.9% | -11.0% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 | 3 | 3 | 3 |
| Debt / EquityFinancial leverage | 0.12x | 0.13x | 1.05x | 0.31x | 0.10x |
| Net DebtTotal debt minus cash | -$64M | -$26M | $3.1B | -$455M | $46M |
| Cash & Equiv.Liquid assets | $154M | $81M | $547M | $680M | $234M |
| Total DebtShort + long-term debt | $90M | $55M | $3.6B | $224M | $280M |
| Interest CoverageEBIT ÷ Interest expense | -15.22x | -104.52x | 4.73x | -33.25x | -16.47x |
HCM leads this category, winning 4 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
RIOT leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in RIOT five years ago would be worth $7,221 today (with dividends reinvested), compared to $770 for CAN. Over the past 12 months, RIOT leads with a +207.5% total return vs ZLAB's -30.3%. The 3-year compound annual growth rate (CAGR) favors RIOT at 32.0% vs CAN's -40.9% — a key indicator of consistent wealth creation.
| Metric | HCMHUTCHMED (China) … | CANCanaan Inc. | MARAMarathon Digital … | ZLABZai Lab Limited | RIOTRiot Platforms, I… |
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -2.5% | -33.1% | +28.2% | +14.1% | +70.3% |
| 1-Year ReturnPast 12 months | -8.8% | -14.1% | -4.7% | -30.3% | +207.5% |
| 3-Year ReturnCumulative with dividends | -14.2% | -79.3% | +36.1% | -46.6% | +129.8% |
| 5-Year ReturnCumulative with dividends | -49.3% | -92.3% | -59.5% | -87.5% | -27.8% |
| 10-Year ReturnCumulative with dividends | +1.0% | -90.1% | -51.6% | -29.2% | +787.3% |
| CAGR (3Y)Annualised 3-year return | -5.0% | -40.9% | +10.8% | -18.9% | +32.0% |
RIOT leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
Evenly matched — HCM and RIOT each lead in 1 of 2 comparable metrics.
Risk & Volatility
HCM is the less volatile stock with a 0.66 beta — it tends to amplify market swings less than CAN's 4.41 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. RIOT currently trades 99.9% from its 52-week high vs CAN's 23.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | HCMHUTCHMED (China) … | CANCanaan Inc. | MARAMarathon Digital … | ZLABZai Lab Limited | RIOTRiot Platforms, I… |
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.66x | 4.41x | 3.11x | 1.21x | 3.87x |
| 52-Week HighHighest price in past year | $19.50 | $2.22 | $23.45 | $44.34 | $24.14 |
| 52-Week LowLowest price in past year | $12.91 | $0.39 | $6.66 | $15.96 | $7.68 |
| % of 52W HighCurrent price vs 52-week peak | +68.3% | +23.2% | +54.2% | +44.6% | +99.9% |
| RSI (14)Momentum oscillator 0–100 | 37.1 | 58.4 | 69.6 | 47.7 | 74.5 |
| Avg Volume (50D)Average daily shares traded | 31K | 9.7M | 47.6M | 729K | 18.4M |
Evenly matched — HCM and RIOT each lead in 1 of 2 comparable metrics.
Analyst Outlook
RIOT leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: HCM as "Buy", CAN as "Buy", MARA as "Buy", ZLAB as "Buy", RIOT as "Buy". Consensus price targets imply 336.9% upside for CAN (target: $2) vs 15.7% for RIOT (target: $28).
| Metric | HCMHUTCHMED (China) … | CANCanaan Inc. | MARAMarathon Digital … | ZLABZai Lab Limited | RIOTRiot Platforms, I… |
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $17.50 | $2.25 | $16.13 | $35.00 | $27.90 |
| # AnalystsCovering analysts | 10 | 6 | 19 | 11 | 18 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | 1 | — | — | 2 |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +1.6% | 0.0% | +1.0% | 0.0% | +0.0% |
RIOT leads this category, winning 1 of 1 comparable metric.
Key Takeaway
HCM leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). RIOT leads in 2 (Total Returns, Analyst Outlook). 1 tied.
Best OverallHUTCHMED (China) Limited (HCM)Leads 2 of 6 categories
Loading custom metrics...
HCM vs CAN vs MARA vs ZLAB vs RIOT: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is HCM or CAN or MARA or ZLAB or RIOT a better buy right now?
For growth investors, Canaan Inc.
(CAN) is the stronger pick with 96. 7% revenue growth year-over-year, versus -24. 8% for HUTCHMED (China) Limited (HCM). HUTCHMED (China) Limited (HCM) offers the better valuation at 60. 5x trailing P/E (41. 7x forward), making it the more compelling value choice. Analysts rate HUTCHMED (China) Limited (HCM) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — HCM or CAN or MARA or ZLAB or RIOT?
Over the past 5 years, Riot Platforms, Inc.
(RIOT) delivered a total return of -27. 8%, compared to -92. 3% for Canaan Inc. (CAN). Over 10 years, the gap is even starker: RIOT returned +787. 3% versus CAN's -90. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — HCM or CAN or MARA or ZLAB or RIOT?
By beta (market sensitivity over 5 years), HUTCHMED (China) Limited (HCM) is the lower-risk stock at 0.
66β versus Canaan Inc. 's 4. 41β — meaning CAN is approximately 566% more volatile than HCM relative to the S&P 500. On balance sheet safety, Riot Platforms, Inc. (RIOT) carries a lower debt/equity ratio of 10% versus 105% for Marathon Digital Holdings, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — HCM or CAN or MARA or ZLAB or RIOT?
By revenue growth (latest reported year), Canaan Inc.
(CAN) is pulling ahead at 96. 7% versus -24. 8% for HUTCHMED (China) Limited (HCM). On earnings-per-share growth, the picture is similar: Canaan Inc. grew EPS 51. 1% year-over-year, compared to -673. 5% for Riot Platforms, Inc.. Over a 3-year CAGR, ZLAB leads at 28. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — HCM or CAN or MARA or ZLAB or RIOT?
HUTCHMED (China) Limited (HCM) is the more profitable company, earning 6.
0% net margin versus -144. 6% for Marathon Digital Holdings, Inc. — meaning it keeps 6. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HCM leads at -6. 9% versus -90. 6% for MARA. At the gross margin level — before operating expenses — ZLAB leads at 58. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is HCM or CAN or MARA or ZLAB or RIOT more undervalued right now?
Analyst consensus price targets imply the most upside for CAN: 336.
9% to $2. 25.
07Which pays a better dividend — HCM or CAN or MARA or ZLAB or RIOT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is HCM or CAN or MARA or ZLAB or RIOT better for a retirement portfolio?
For long-horizon retirement investors, HUTCHMED (China) Limited (HCM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
66)). Canaan Inc. (CAN) carries a higher beta of 4. 41 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HCM: +1. 0%, CAN: -90. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between HCM and CAN and MARA and ZLAB and RIOT?
These companies operate in different sectors (HCM (Healthcare) and CAN (Technology) and MARA (Financial Services) and ZLAB (Healthcare) and RIOT (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: HCM is a small-cap quality compounder stock; CAN is a small-cap high-growth stock; MARA is a small-cap high-growth stock; ZLAB is a small-cap high-growth stock; RIOT is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
Revenue Growth>
%
(HCM: -9.2% · CAN: 121.1%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.